1 H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
申请人:Kruse G. Cornelis
公开号:US20050054679A1
公开(公告)日:2005-03-10
The present invention relates to a group of novel 1H-imidazole derivatives, to methods for the preparation of these compounds, and to pharmaceutical compositions containing one or more of these compounds as an active component.
These 1H-imidazole derivatives are potent cannabinoid-CB
1
receptor agonists, partial agonists or antagonists, useful for the treatment of psychiatric and neurological disorders, as well as and other diseases involving cannabinoid neurotransmission.
The compounds have the general formula (I)
wherein R and R
1
-R
4
have the meanings given in the specification.
本发明涉及一组新颖的1H-咪唑衍生物,以及制备这些化合物的方法和含有这些化合物中的一个或多个作为活性成分的药物组合物。这些1H-咪唑衍生物是有效的大麻素-CB1受体激动剂、部分激动剂或拮抗剂,可用于治疗精神疾病和神经系统疾病,以及其他涉及大麻素神经传递的疾病。这些化合物具有通式(I),其中R和R1-R4的含义如规范中所述。